Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002065881-25-000025
Filing Date
2025-06-16
Accepted
2025-06-16 20:17:27
Documents
3
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750119440.html 4  
1 FORM 4 wk-form4_1750119440.xml 4 6237
2 EX-24.1 curranpowerofattorney.htm EX-24.1 4308
3 curranpowerofattorney001.jpg GRAPHIC 255730
  Complete submission text file 0002065881-25-000025.txt   364440
Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 251051621

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)